PDS Biotechnology Corporation (PDSB) Cash Flow Annual - Discounting Cash Flows
PDSB
PDS Biotechnology Corporation
PDSB (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
2013
12-31
2012
12-31
Report Filing: 2025-05-14 2025-03-27 2023-12-31 2023-04-28 2022-03-31 2021-03-18 2020-03-27 2019-02-21 2018-03-01 2017-03-02 2016-03-08 2014-12-31 2013-12-31 2012-12-31
Net Income/Starting Line -35.5 -37.61 -42.94 -40.85 -16.92 -14.85 -7 -40.87 -50.86 -38.82 -28.08 -12.2 -6.88 -4.7
Cash From Operating Activities -34.12 -35.03 -33.64 -25.71 -12.49 -13.15 -18.07 -33.15 -40.7 -32.19 -21.75 -9.71 -8.04 -2.25
Depreciation and Amortization 0.051 0.021 0.017 0 0.005 0.016 0.098 0.069 0.183 0.1 0.053 0.031 0.004 0.002
Deferred Income Tax 0 0 -1.97 0 0 0 -0.382 2.82 0.141 0.269 0.199 0.035 0 0
Stock Based Compensation 6.47 6.85 7.61 5.2 4.11 0.452 3.18 7.62 6.4 5.3 2.9 1.3 0.26 0
Other Non-Cash Items 1.67 1.46 3.84 5.47 0.241 0.161 -9.36 0.532 0.364 0.176 2.12 -0.576 0.854 0.348
Changes in Working Capital -6.79 -5.75 -0.199 4.47 0.076 1.07 -4.61 -3.43 3.07 0.782 1.26 1.7 -2.28 2.1
Accounts Receivable 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Accounts Payable -3.14 -5.3 5.76 -0.09 -0.106 0.218 -1.98 -3.97 0.898 1.42 -0.072 0.527 -1.66 0
Deferred Revenue -3.65 -0.454 -5.96 4.57 0.182 0.852 -2.63 0.541 2.18 -0.638 1.33 1.17 -0.62 2.1
Other Working Capital 0.001 -0 -0 0 0 0 -0 0.001 -0 -0 -0 0 -0 -0
Cash From Investing Activities -29 -0.029 0 0 0 0 29.38 0 -0.189 -0.687 -1.3 -0.885 -0.137 -0.001
Investments in Property Plant and Equipment -0 -0.029 -0 0 0 0 0 0 -0.189 -0.687 -1.3 -0.885 -0.137 -0.001
Payments for Acquisitions 0 0 0 0 0 0 29.11 0 0 0 0 0 0 0
Purchases of Securities 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sales and Maturities of Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Investing Activities -29 0 0 0 0 0 0.275 0 0 0 0 0 0 0
Cash From Financing Activities 7.5 20.19 16.38 34.29 48.89 29.83 0.75 -20.27 22.55 9.09 139.5 16.47 15.9 2.37
Debt Repayment -6.31 -3.18 -0.059 25 0 0 0 -0.016 5 9.53 2.47 1.55 0.1 0.15
Common Stock Issued 10.4 22.59 16.13 9.86 48.55 29.76 0.75 1.51 17.38 -0.23 86.06 0 0 2.22
Common Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 -0.022 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 7,030 0.774 0.309 -0.569 0.344 0.07 0.75 1.51 0.171 -0.219 50.99 13.47 15.82 0
Effect of Forex Changes on Cash 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Change in Cash -17.75 -14.87 -17.26 8.58 36.4 16.68 12.06 -53.42 -18.33 -23.79 116.5 5.87 7.72 0
Cash at Beginning of Period 57.73 56.56 73.82 65.24 28.84 12.16 0.104 88.07 106.4 130.2 13.73 7.86 0.141 0
Cash at End of Period 39.98 41.69 56.56 73.82 65.24 28.84 12.16 34.65 88.07 106.4 130.2 13.73 7.86 0.141
Free Cash Flow -34.15 -35.06 -33.64 -25.71 -12.49 -13.15 -18.07 -33.15 -40.89 -32.88 -23.06 -10.6 -8.18 -2.25
Operating Cash Flow -34.12 -35.03 -33.64 -25.71 -12.49 -13.15 -18.07 -33.15 -40.7 -32.19 -21.75 -9.71 -8.04 -2.25
Capital Expenditure -0.029 -0.029 -0 -0 -0 -0 -0 -0 -0.189 -0.687 -1.3 -0.885 -0.137 -0.001
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us